Targeting succinate metabolism to decrease brain injury upon mechanical thrombectomy treatment of ischemic stroke.

No Thumbnail Available
Change log
Mottahedin, Amin 
Prag, Hiran A 
Dannhorn, Andreas 
Mair, Richard 
Schmidt, Christina 

Current treatments for acute ischemic stroke aim to reinstate a normal perfusion in the ischemic territory but can also cause significant ischemia-reperfusion (IR) injury. Previous data in experimental models of stroke show that ischemia leads to the accumulation of succinate, and, upon reperfusion, the accumulated succinate is rapidly oxidized by succinate dehydrogenase (SDH) to drive superoxide production at mitochondrial complex I. Despite this process initiating IR injury and causing further tissue damage, the potential of targeting succinate metabolism to minimize IR injury remains unexplored. Using both quantitative and untargeted high-resolution metabolomics, we show a time-dependent accumulation of succinate in both human and mouse brain exposed to ischemia ex vivo. In a mouse model of ischemic stroke/mechanical thrombectomy mass spectrometry imaging (MSI) shows that succinate accumulation is confined to the ischemic region, and that the accumulated succinate is rapidly oxidized upon reperfusion. Targeting succinate oxidation by systemic infusion of the SDH inhibitor malonate upon reperfusion leads to a dose-dependent decrease in acute brain injury. Together these findings support targeting succinate metabolism upon reperfusion to decrease IR injury as a valuable adjunct to mechanical thrombectomy in ischemic stroke.

Journal Title
Redox Biol
Conference Name
Journal ISSN
Volume Title
Elsevier BV
Wellcome Trust (220257/Z/20/Z)
MRC (MC_UU_00028/4)
Medical Research Council (MC_UU_12022/6)
Cancer Research UK (A27453)
European Research Council (819920)